Results from a "highly promising pilot study" presented at the 68th annual American Academy of Neurology meeting in Canada have shown Lipoic acid is safe, well tolerated, and offers neuroprotection...
Results from new research suggest that maternal illness and pesticide-related environmental exposure contribute to risk of pediatric-onset multiple sclerosis (MS), whereas cesarean-section delivery...
Once-daily Gilenya therapy is effective after four years of real-world clinical use among patients with relapsing remitting multiple sclerosis (RRMS), and has a safety profile that is “broadly...
Researchers from the United Kingdom have identified that men with gender identity disorder (GID) who took sex hormones to undergo a male-to-female conversion had a nearly seven-fold higher risk of...
Research suggests gut bacteria may directly affect brain structure and function, and could offer new ways to treat multiple sclerosis and psychiatric conditions.
Far from being silent partners that...
John Quarles, an associate professor of computer science at The University of Texas at San Antonio (UTSA), has developed a new virtual reality method of aquatic physical therapy.
Quarles’s game,...
The findings of a systematic review suggests adolescent obesity could be a risk factor for multiple sclerosis. If future research supports this idea, it “would be of major significance,” according to...
Patients with multiple sclerosis say they may be wary if their physician gets paid to recruit for clinical trials, a survey has found.
Some 61 per cent of MS patients who'd never participated in a...
Urinary tract symptoms affect a large proportion of patients with multiple sclerosis (MS), yet their extent and type is not well-known. A study reported that among a cohort of people with the disease...
A common antihistamine used to treat symptoms of allergies and the common cold, called clemastine fumarate, partially reversed damage to the visual system in people with multiple sclerosis (MS) in a...
